News

Posted: March 20, 2013 | Press

Stanley Lau Appointed as Chief Executive Officer of Amsino Medical Group

Stanley Lau Appointed as Chief Executive Officer of Amsino Medical Group

Shanghai, China, Tuesday, March 5, 2013 - Amsino Medical Group announces today that Stanley Lau has been appointed as the company’s Chief Executive Officer. 

“I am very pleased to join Amsino as its CEO. I have been impressed by the company’s core competencies, quality systems, technology, and customer base”, said Lau, “Amsino is a dynamic company with exceptional prospects for growth in both developed markets as well as in emerging markets. I look forward to working with the executive team closely and growing the company into the next level.”

Stanley brings to Amsino, over 30 years of experience in the medical/pharmaceutical industry. He worked at a senior executive level for several major global firms including Baxter Healthcare, Pharmacia, Merck, and Pfizer. Stanley is a dynamic, enthusiastic, high-achieving business leader with a very successful track record. He brings a wealth of knowledge from his combined experiences in general corporate management, sales, marketing, distribution, people development, business development, and governmental affairs. He is a strategic thinker, and is very strong in strategy development, execution and business development. He has worked in China, US, UK and a few Asian countries in the past 30 years. Stanley holds a bachelor degree of pharmacy, University of London. He is a registered pharmacist in London and Hong Kong.

Commenting on the appointment, Dr. Richard Lee, Founder and Chairman of the Board of Directors of Amsino Medical Group said, “I have known Stanley since 2006 and I always admire him for what he has accomplished in his career and I hold Stanley in very high esteem for his kind nature, graciousness as well as his business acumen. We are very fortunate to have Stanley join us, he brings considerable new skills and experience to the business and enhancing Amsino’s corporate governance, management, and operational excellence”, Dr. Lee continued to say, “I look forward to working with Stanley and the management team in maximizing growth opportunities ahead of us”.

About Amsino Medical Group, Ltd.: Based in the US, Amsino has provided high value medical products to the US and global markets since 1993, and has offices and three FDA-registered factories in China. Amsino is a leading medical device company dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that improve the safety and effectiveness of patient care. Amsino’s portfolio includes urological products, IV infusion products and access devices, enteral feeding and irrigation products, respiratory therapy products under AMSure® and AMSafe® brands, and a full-service contract manufacturing business. Amsino products are distributed in the United States and more than 30 other countries worldwide. www.amsino.com